Publikationen in Zusammenarbeit mit Forschern von University Medical Center Utrecht (9)

2016

  1. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: A cross-national descriptive study from the PROTECT-EU Project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 56-65

  2. Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): A methodological approach to assess consistencies across databases from the PROTECT-EU project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 66-78

  3. Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 156-165

  4. The IMI PROTECT project: Purpose, organizational structure, and procedures

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 5-10

  5. Understanding inconsistency in the results from observational pharmacoepidemiological studies: The case of antidepressant use and risk of hip/femur fractures

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 88-102

2014

  1. Antidepressant prescribing in five European countries: Application of common definitions to assess the prevalence, clinical observations, and methodological implications

    European Journal of Clinical Pharmacology, Vol. 70, Núm. 7, pp. 849-857

  2. Bridging differences in outcomes of pharmacoepidemiological studies: Design and first results of the PROTECT project

    Current Clinical Pharmacology, Vol. 9, Núm. 2, pp. 130-138

  3. Incidence rates and trends of hip/femur fractures in five European countries: Comparison using e-healthcare records databases

    Calcified Tissue International, Vol. 94, Núm. 6, pp. 580-589

2007

  1. European Surveillance of Antimicrobial Consumption (ESAC): Quality indicators for outpatient antibiotic use in Europe

    Quality and Safety in Health Care, Vol. 16, Núm. 6, pp. 440-445